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1. Introduction 
The value of perfusion scintigraphy in the detection of pulmonary embolism (PE) was 
demonstrated as early as 1964 by Wagner et al. PE causes perfusion defects that conform to 
the anatomical distribution of the pulmonary vascular bed. Perfusion defects in acute PE are 
therefore of sub-segmental, segmental or lobar character. Ventilation is normally preserved 
in these areas and the observed wedge shaped mismatch between ventilation and perfusion 
is typical for PE. Planar ventilation/perfusion scintigraphy (V/P scan) was until the 1990s 
the method of choice for studying patients with suspected PE. However, the large 
Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED I), showed a high 
number of non-diagnostic examinations (65%) with V/P scan and the probabilistic 
interpretation criteria were confusing to the clinicians (Gray et al., 1993; The PIOPED 
Investigators, 1990). Planar imaging has become obsolete, particularly when the issue is 
identification and quantification of focal or regional aberration of organ function. 
The advantage of three dimensional tomography over planar imaging for PE detection had 
already been shown in 1983 in a study on dogs (Osborne et al., 1983). Furthermore, Magnussen 
et al. (1999) used a computerized model of PE to highlight the advantage of SPECT over planar 
imaging in the assessment of the size and location of perfusion defects. Using a dual head 
camera, Palmer et al. (2001), developed a fast and efficient method for ventilation/perfusion 
tomography (V/P SPECT ) for clinical practice with total acquisition time of only 20 minutes. 
Moreover, they developed an algorithm to calculate the quotient between ventilation and 
perfusion and to present it as V/Pquotient images. This facilitated PE diagnosis and the 
quantification of PE extension, which led to the use of the term quantitative V/P SPECT. Using  
a porcine model, Bajc et al. validated  V/P SPECT  for diagnosis of PE and confirmed the 
superior value of tomography over planar imaging with excellent interobserver agreement of 
defects down to the sub-segmental level (Bajc et al., 2002b).  
The objective of this chapter is to acquaint readers with the latest methodological approach 
of V/P SPECT in the diagnosis of PE, in accordance with the new guidelines of the 
European Association of Nuclear Medicine (Bajc et al., 2009a, b). In this chapter we also 
discuss the value of V/P SPECT in the follow up after acute PE and in the diagnosis of other 
cardiopulmonary diseases.  
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Efficient and effective diagnostics for PE and other diseases should meet the following basic 
requirements: 
 Fast procedure and prompt availability of results 
 Feasibility for all patients 
 High diagnostic accuracy and few non-diagnostic reports 
 Low radiation dose 
 Utility for selection of treatment strategy 
 Suitability for follow up and research 
 
 
Fig. 1. V/P SPECT images of a patient with normal ventilation (V) and perfusion (P).  
Techn = Technegas, MAA = Macroaggregated albumin  
2. Ventilation and perfusion imaging 
In healthy patients, regional ventilation and perfusion match each other to optimize gas 
exchange (Fig 1). In diseased patients, changes in distribution of ventilation or perfusion or 
both are common. Vascular occlusive diseases, like PE, cause perfusion defects in 
conformity with pulmonary circulation while ventilation stays intact in these areas. This 
disconcordant ventilation/perfusion pattern, so called mismatch, provides the basis for PE 
diagnosis. Ventilation might be disturbed in acute PE due to bronchial constriction 
(Giuntini, 2001) but perfusion defects are usually observable in other areas (Fig 2a). 
Ventilation commonly shows disturbances in lung diseases like pneumonia, tumours and 
obstructive diseases. Such perfusion patterns are essential to recognize as they provide 
additional specificity and significance to observed conditions.  
2.1 Ventilation 
For the ventilation study, gases may be used as they are distributed strictly according to 
regional ventilation. The gas that is used for V/P SPECT is metastable 81-krypton (81mKr). 
Its short half life, 13 s, implies that it disappears from the alveoli by decay at a much faster 
rate than by exhalation. Therefore, after a few minutes of breathing the test gas, the alveolar  
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Fig. 2. A patient with acute PE. Sagittal ventilation (V), perfusion (P) and V/P quotient 
(V/Pq) images of the right lung. A) At the initial examination, segmental perfusion defects 
are seen (arrow). The V/P mismatch is clearly delineated on V/P quotient images which 
improves visualization. Reduced ventilation is observed in posterior parts of the lung, 
where perfusion is preserved (blue arrows). B) Normalization of ventilation (blue arrows 
and perfusion is seen already after three days. 
concentration will reflect alveolar ventilation. Ventilation is performed during continuous 
breathing of this gas. 81mKr has higher gamma energy than 99m-Technetium (99mTc) (191 
compared to 140 keV) allowing simultaneous imaging of ventilation and perfusion. 81mKr 
is diluted from a rubidium generator that has a half life of 4.6 h. Its availability is limited 
and it is too expensive for general use. 
Routinely in clinical practice, inhalation of a radio-aerosol is used for ventilation 
scintigraphy. Aerosol particles are liquid or solid. The size of the particles is of critical 
importance. Particles larger than 2 μm are deposited in large airways. Smaller particles are 
deposited by sedimentation and diffusion in small airways and alveoli. Particles smaller 
than 1 μm, are mainly deposited in alveoli by diffusion. Aerosol deposition is modified by 
flow pattern. High flow rates at forced breathing patterns and turbulent flow enhances 
particle deposition in airways and increases the likelihood of hot spots formation on 
ventilation images, particularly in Chronic Obstructive Pulmonary Disease (COPD).  
Diethylenetriaminepentaacetic acid labeled with technetium, 99mTc-DTPA, is the most 
common agent used for ventilation scintigraphy. It is soluble in water and the size of the 
molecule is 492 Dalton. The average size of particles after nebulization is at best 1.3 to 1.8 
μm. Due to the water solubility, particle size tends to increase during inhalation and to 
agglutinate in cases of bronchial obstruction where there are turbulent flows; this leads to 
the creation of hot spots. Because of the water solubility, 99mTc-DTPA particles also diffuse 
through the alveolo-capillary membrane to the blood. In a healthy patient, clearance of 
99mTc-DTPA occurs with a half life of about 70 minutes. Increased clearance, leading to a 
shorter half life is observed where there is alveolar inflammation for any reason, such as 
alveolitis of an allergic or toxic nature and even in smokers. Clearance of 99mTc-DTPA can 
for diagnostic purposes be measured at a routinely performed V/P SPECT.  
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Technegas is a newer solid aerosol with extremely small carbon particles, 0.005-0.2 μm, 
labeled with 99mTc which are generated in a high temperature furnace. The small particle 
size implies that they are distributed in the lungs almost like a gas and are deposited in 
alveoli by diffusion (James et al., 1992). Technegas provides images which are equivalent to 
those with 81mKr. Technegas significantly reduces problems of central airway deposition 
and peripheral hotspots. Patients routinely admitted for V/P SPECT and a group of patients 
with known COPD were recently studied with both 99mTc-DTPA and Technegas showing 
superiority of the latter (Jögi et al., 2010). Unevenness of radiotracer deposition and degree 
of central deposition were significantly reduced with Technegas, particularly in the 
obstructive patients (Fig 3). In some patients, mismatched perfusion defects were only 
identified using Technegas because the significant peripheral unevenness of 99mTc-DTPA 
obscured mismatch. PE might have been overlooked in COPD patients using 99mTc-DTPA. 
In a few patients, 99mTc-DTPA yielded images of very poor quality. Technegas is therefore 
recommended as the superior radio-aerosol, particularly in patients with obstructive lung 
disease. A further advantage of Technegas is that relatively few breaths are sufficient to 
achieve an adequate amount of activity in the lungs. 
 
 
Fig. 3. Comparison between 99mTc-DTPA and Technegas ventilation studies in a patient 
with COPD.  
2.2 Perfusion 
Perfusion scintigraphy involves an intravenous injection of radio-labeled macro-
aggregates of albumin (MAA), sized 15-100 μm, which cause microembolization of 
pulmonary capillaries and pre-capillary arterioles in amounts reflecting regional 
perfusion. At least 60 000 particles are required to obtain a representative activity 
distribution (Heck & Duley, 1974). Routinely, about 400 000 particles are injected. As there 
are over 280 billion pulmonary capillaries and 300 million pre-capillary arterioles, only a 
very small fraction of the pulmonary bed will be obstructed. A preparation of 100 000-
200 000 particles is recommended for patients with known pulmonary hypertension or 
after a single lung transplant. Degradation of MAA results in its elimination from the lung 
within a few hours. 
2.3 Acquisition   
To perform V/P SPECT takes only one hour from referral to report (Bajc et al., 2004; Palmer 
et al., 2001). The ventilation study starts with inhalation of 25-30 megabecquerel (MBq) 
Technegas, usually 2-3 breaths. Immediately after ventilation SPECT, a dose of 100-120 MBq 
99mTc-MAA is given intravenously for perfusion imaging. 
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During the examination, the supine patient carefully maintains the position between 
ventilation and perfusion acquisitions. Immobilization for only 20 minutes is well tolerated 
by nearly all patients. Examination in supine position is comfortable even for critically ill 
patients. It is also more convenient for the staff. It is noteworthy that V/P SPECT can be 
performed in all patients, since there is no contraindication related to age, radiation, contrast 
media or co-morbidity.  
2.4 Reconstruction and calculation of V/P quotient images 
Iterative OSEM is essential for SPECT reconstruction. Ventilation activity is subtracted from 
perfusion images. A valuable parameter in clinical SPECT is the Ventilation/Perfusion 
quotient, V/Pquotient  (Bajc et al., 2004; Palmer et al., 2001). V/Pquotient is calculated after 
normalization of ventilation counts to perfusion counts. Hot spot removal is important, 
especially when 99mTc-DTPA is used.  
2.5 Presentation of V/P
 
SPECT 
V/P SPECT images are usually presented in frontal, sagittal and transversal projections, 
available in any modern system. The slices must be accurately aligned so that ventilation 
and perfusion slices match each other for correct comparison. Therefore, it is crucial to 
achieve this acquisition in one session with maintained body position. This is also a 
prerequisite for the calculation of V/Pquotient images, which greatly facilitates identification 
of ventilation/perfusion mismatches typical of PE as well as other patterns characteristic of 
other pulmonary diseases. 
Volume rendered images, such as “Maximum Intensity Projection” are available with 
almost all SPECT systems, allowing rotating 3D views. This function is another valuable 
option, particularly for quantification and follow-up of PE patients. 
3. Interpretation 
According to the new European guidelines, the holistic interpretation of lung SPECT is 
recommended (Bajc et al., 2009b). The clinician can only benefit from reports, which clearly 
express the presence or absence of PE. This goal was not achieved with previous 
probabilistic reporting methods according to PIOPED or modified PIOPED. Large V/P 
SPECT studies show that this is achievable if all patterns are considered, where these 
combine ventilation and perfusion. Conclusive reports were given in 97 to 99 % of studies. 
Holistic interpretation of V/P SPECT should be based upon: a) Clinical pre-test probability 
and b) the application of criteria for interpreting V/P patterns to distinguish between 
patterns indicative of PE and other diseases. 
3.1 Criteria for acute PE according the european guidelines 
In accordance with the guidelines of the European Association of Nuclear Medicine (Bajc et 
al., 2009a, b), PE is reported if there is:  
 V/P mismatch of at least one segment or two sub-segments that conforms to the 
pulmonary vascular anatomy.  
No PE is reported if there is: 
 normal perfusion pattern conforming to the anatomic boundaries of the lungs,   
 matched or reversed mismatch V/P defects of any size, shape or number in the absence 
of mismatch  
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 mismatch that does not have a lobar, segmental or sub-segmental pattern  
Non-diagnostic for PE is reported if there are: 
 Multiple V/P abnormalities not typical of specific diseases.  
The fundamental point is that lobar, segmental or sub-segmental V/P mismatch serves as 
the basis for confirming a diagnosis of PE among patients with suspected PE. Howarth et al. 
state that: “at least 0.5 of a segment of ventilation/perfusion mismatch is considered 
diagnostic of PE” (Howarth et al., 2006). This simplified criterion gave the highest combined 
sensitivity and specificity, observer reproducibility and fewest indeterminate results. In PE, 
a mismatch has its base along the pleura and conforms to known sub-segmental and 
segmental vascular anatomy (Miniati et al., 1996). Applying these principles of 
interpretation, recent V/P SPECT studies of more than 3000 cases showed a negative 
predictive value of 97-99 %, a sensitivity of 96-99%, and a specificity of 91-98% for PE 
diagnosis (Bajc et al., 2008; Leblanc et al., 2007; Lemb & Pohlabeln, 2001; Miniati et al., 1996; 
Reinartz et al., 2004). The rate of non-diagnostic findings was 1-3%. V/P SPECT yields 
ventilation and perfusion images in exactly the same projections, facilitating recognition of 
mismatch. This is of particular importance in the middle lobe and lingula where mismatch 
may be overlooked if the lung is not accurately delineated by its ventilation images 
(Meignan, 2002).  
 
 
Fig. 4. Patient with massive PE. A) Absent perfusion is seen in the right lung and sub-
segmental perfusion defects are seen in the left lung (arrows). B) After approximately one 
week of anticoagulant therapy. C) The day after thrombolysis.  
Furthermore, V/P SPECT allows quantification of PE extension which is a prerequisite for 
individual treatment of PE. As suggested by Olsson et al., the number of segments and sub-
segments indicating PE are counted and expressed in % of the total lung parenchyma 
(Olsson et al., 2006). Moreover, areas with ventilation abnormalities were recognized 
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allowing estimation of the degree of total lung malfunction. A segmental reduction or a sub-
segmental total deficiency of function is attributed 1 point, a segmental total deficiency, 2 
points. Each lung comprises according to our charts 9 segments, representing 18 points. 
Mismatch defects are expressed as mismatch points, which after division by 36 give the 
fraction of the lung that is embolised. Regions with ventilation or perfusion defects are 
totalled in order to estimate the reduction in overall lung function.  
The study showed that patients with up to 40 % PE could be safely treated at home if 
ventilation abnormalities engaged less than 20 % of the lung. Since 2004, the Skåne 
University Hospital, Lund, has successfully treated more than 2000 patients with PE and 
about 60 % of these patients were treated at home. 
3.2 Diagnosis of pulmonary embolism  
In PE, an embolus blocks the blood flow, causing a perfusion defect, while ventilation 
remains normal because there is no corresponding blockage in the airway. To characterize 
the pattern of perfusion defects is crucial. Perfusion defects due to blockage of a pulmonary 
artery should reflect the branching of pulmonary circulation and its classical segmental 
anatomy. A segmental defect is wedge shaped with its base on the pleura.  
On V/P SPECT images, it is relatively easy to identify segmental and sub-segmental 
patterns of perfusion defects. Figure 4a shows multiple perfusion defects in acute stage in a 
female patient with chest pains, who had fainted outside the hospital. Applying 
quantification on V/P SPECT images, extension of PE was estimated to be ca 60%. The 
patient was treated first with heparin for a week. However, Follow up showed limited 
regression (Fig 4b). As brain hemorrhage was excluded, thrombolysis was administered. 
The following day perfusion was normalized (Fig 4c).  
Figure 2 shows sagittal slices of right lung of a patient studied for acute breathlessness. A 
segmental perfusion defect was well delineated, in perfusion and V/Pquotient images (Fig 2a). 
Moreover, it was possible to see broncho-constriction in the posterior part of the lung (blue 
arrow). The extension of perfusion defect was estimated at 10% and ventilation defect 25%. 
Three days later nearly complete resolution of the embolus was observed, as well as 
normalization of the ventilation (Fig 2b). 
In planar images, the identification of a solitary segmental perfusion defect within middle 
lobe and lingula is often impossible or, at best, difficult. With tomographic images these 
changes are well delineated.  
It is important to be aware that mismatch findings not having segmental character do  
not usually represent PE. Non segmental mismatch means that perfusion defects do  
not conform to segmental anatomy and are caused by other diseases. This is observed  
in patients with heart failure (Jögi et al., 2008), pneumonia, mediastinal adenopathy,  
post radiation therapy etc. Total absence of perfusion in one lung without any  
other region of mismatch is often caused by pathology other than PE, such as a central 
tumour or abscess. 
3.3 Follow up 
Follow up is a frequently overlooked aspect of diagnostic strategies although it is essential 
both for clinical and scientific reasons. The follow up is necessary to assess the effect of 
treatment, especially to see the effect of anticoagulant therapy (Fig 4b) and in these cases to 
be able to adjust therapy or, if necessary, continue with thrombolysis (Fig 4c). 
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Moreover follow up is important  
 To assess the need for prolonged oral anticoagulation beyond 6 months, where there are 
extensive remnants of PE.  
 To allow differentiation between new and old PE, where a recurrence of PE is 
suspected. 
 To explain physical incapacity after PE in case of permanently impaired lung function. 
 To evaluate and compare drugs and treatment strategies.  
 To identify patients with remaining perfusion defects after treatment as these could be  
particularly susceptible to developing pulmonary hypertension  
For follow up, V/P SPECT is the only suitable method for the following reasons: 
 Detection of all emboli requires that the whole lung is examined with a sensitive 
method. 
 The cumulative radiation dose is a central issue when the indication for PE is relative  
 V/P SPECT is the only method which enables functional impairment to be determined 
due to increased dead space from non-perfused lung units and increased pulmonary 
vascular resistance due to a reduced vascular bed.  
To be able to study the efficacy of treatment, in individual patients the same method should 
be used both for diagnosis and follow up. This is a further strong argument in favour of V/P 
SPECT as the primary diagnostic method for PE. 
 
 
Fig. 5. Patient with chronic PE. Frontal slices. Multiple perfusion defects are seen (arrows). 
MDCT was normal. 
3.4 Chronic pulmonary embolism  
Chronic PE is a progressive disease that develops in about 5 % of patients, even after treatment 
(Begic et al., 2011; Pengo et al., 2004), after an acute episode of PE . However, it often has an 
insidious onset. It might lead to pulmonary hypertension, right heart failure and arrhythmia, 
which are frequent causes of death. The value of ventilation/perfusion scintigraphy is well 
established. It has recently been confirmed in a head to head comparison between MDCT and 
planar scintigraphy with pulmonary angiography as reference. Among patients with 
pulmonary hypertension, scintigraphy had a sensitivity of 96-97% and specificity of 90 %, 
while MDCT had a sensitivity of 51% (Tunariu et al., 2007). The conclusion was that 
ventilation/perfusion scintigraphy “has a higher sensitivity than MDCT as well as very good 
specificity in detecting chronic pulmonary thromboembolic disease as a potentially curable 
cause of pulmonary hypertension”. Scintigraphic features of chronic PE vary. Figure 5 
illustrates a case of multiple perfusion defects which are similar to acute PE. MDCT was 
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normal. In some patients mismatch without clear segmental or sub-segmental pattern is 
observed. Peripheral zones of the lung lack perfusion. The centre of the lung is hyperperfused. 
The lung appears significantly smaller on perfusion images compared to ventilation and the 
V/Pquotient images show mismatch along the lung periphery (Fig 6). 
In recent guidelines for the diagnosis and treatment of pulmonary hypertension it is stated 
that “ventilation/perfusion scan remains the screening method of choice for chronic 
pulmonary hypertension” (Galie et al., 2009). It was also pointed out that pulmonary veno-
occlusive disease is a rare but important differential diagnosis. 
 
 
Fig. 6. Patient with pulmonary hypertension caused by chronic PE. Peripheral zones of the 
lung lack perfusion (arrows). The centre of the lung is hyperperfused .V/Pquotient images 
shows mismatch along the lung periphery.  
4. Sensitivity and specificity of V/P SPECT and other methodological 
considerations 
In a clinical study, 53 % more mismatch points were identified with V/P SPECT compared 
to planar technique (Bajc et al., 2004). Similar results have been found by others (Gutte et al., 
2010; Reinartz et al., 2001). SPECT eliminates superimposed structures, clarifying segmental 
and sub-segmental nature of perfusion defects caused by PE. 
The value of V/P SPECT is further confirmed in clinical studies (Bajc et al., 2008; Gutte et al., 
2009; Leblanc et al., 2007; Lemb & Pohlabeln, 2001). V/P SPECT  is today the recommended 
method for clinical diagnosis, follow up and research (Bajc et al., 2009b). 
Powell reported that sensitivity and specificity of CT for central PE are about 90% (Powell & 
Muller, 2003). Perrier et al. found in a broad clinical material that CT had a sensitivity of 70% 
for PE and a specificity of 91 % (Perrier et al., 2001). They concluded: “clinical CT should not 
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be used alone for suspected PE but could replace angiography in combined strategies that 
include ultrasonography and lung scanning”. Likewise, van Strijen et al. found in a 
multicentre prospective study that sensitivity of CT was 69% while specificity was 84% and 
“concluded that the overall sensitivity of spiral CT is too low to endorse its use as the sole 
test to exclude PE” and that “this holds true even if one limits the discussion to patients with 
larger PE in segmental or larger pulmonary artery branches” (Van Strijen et al., 2005). Our 
experience supports this view. Also, CT as a second procedure following scintigraphy has 
limited value (van Strijen et al., 2003). Multislice CT seems to improve resolution but 
sensitivity for small PE appears not to be improved (Stein et al., 2006). 
A problem associated with limited sensitivity of CT and incomplete coverage of the total 
lung is that the degree of embolism and lung function deficiency cannot be quantified. 
Quantification is important for treatment selection.  
In spite of excellent diagnostic qualities of V/P SPECT and documented low sensitivity of 
CT, the latter method is often recommended. A high number of non-diagnostic 
scintigraphies were reported in the PIOPED study (65%) (1990). This is still used as an 
argument against lung scintigraphy. In PIOPED, scintigraphy was performed with inferior 
technique and inflexible sub-optimal interpretation criteria. Even with planar scintigraphy, a 
reduction in the number of non-diagnostic reports to 10% can be achieved with adequate 
acquisition and a holistic interpretation strategy (Bajc et al., 2002a). With V/P SPECT, this 
number is further reduced to between 1 and 4%, as found in several studies (Bajc et al., 2008; 
Leblanc et al., 2007; Lemb & Pohlabeln, 2001). 
Some practitioners hold that sub-segmental emboli are of little importance for otherwise 
healthy people and may be left untreated and, as a consequence, are prepared to accept less 
sensitive methods for PE diagnosis. However, small emboli are important because they 1) 
may be a first and only sign of silent deep venous thrombosis, 2) may precede larger emboli 
3) if not diagnosed and/or untreated, further episodes may lead to chronic PE and 
pulmonary hypertension (Fig. 6). 4) form a threat to patients with limited cardio-pulmonary 
reserve, 5) are clinically essential for quantification, which is necessary to scientifically 
establish appropriate treatment protocols. Thus, each embolus is relevant, irrespective of 
size. Sub-segmental emboli should not be left untreated without further scientific evidence. 
5. Selection of therapeutic strategy 
Management of PE was previously confined to in-hospital therapy, using anticoagulation, 
heparin injections followed by oral anticoagulants for extended periods of time. 
About 20 % to 55 % of patients with deep venous thrombosis have concomitant PE, which is 
usually not diagnosed because symptoms of PE are absent. Outpatient treatment of patients 
with deep venous thrombosis, which is perceived as a safe routine, implies that many 
patients with PE are treated at home. Home treatment of patients with diagnosed PE has 
been suggested (Kovacs et al., 2000) but in order to determine the appropriateness of the 
treatment on an individual basis, the extension of PE obviously need to be estimated. Whilst 
patients with limited extension of PE may be treated at home, intermediate cases and 
patients with co-morbidity may need in-hospital treatment. Those with very extensive PE 
may require thrombolysis, necessitating inpatient treatment. 
Obviously, quantification requires studies of the whole lung with methods allowing 
identification of large and small emboli. V/P SPECT is the ideal method for this purpose as 
segmental and sub-segmental emboli can be both detected with a high degree of sensitivity 
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and quantified in terms of mismatch points. In a prospective study Olsson et al. studied 102 
out-patients with a moderate degree of PE (up to 40%) (Olsson et al., 2006). After only 5 
days, embolism diminished by 44 % on average. There was no tromboembolic mortality in 
the trial. Later follow up indicated that PE had not recurred in patients showing resolution 
after 5 days. Since 2004, more than 1000 patients, of Skåne University Hospital, Lund, with 
up to 50% extension of PE have been treated as out-patients. After this positive experience, 
out-patient treatment is now perceived as a safe routine in patients who have been selected 
on the basis of V/P SPECT and relevant clinical information.  
6. Additional findings 
PE is a condition known for its non-specific symptoms. Medical imaging, such as 
V/P SPECT, is therefore necessary to confirm or exclude the diagnosis among patients with 
suspected PE. The majority of patients that are examined with V/P SPECT, due to the initial 
assumption of PE, will not have PE. It is therefore important that any alternative diagnoses, 
which could explain the patients’ symptoms, are identified and provided to the referring 
physician. Possible alternative diagnoses include pneumonia, heart failure, pleural fluid, 
malignancy and chronic obstructive pulmonary disease (COPD) (Richman et al., 2004). 
Another important aspect is that these conditions sometimes coexist and that they also 
elevate the risk of PE (Elliott et al., 2000). V/P SPECT can be employed to identify other 
diagnoses than PE.  
6.1 Chronic obstructive pulmonary disease 
COPD is a major cause of both morbidity and mortality globally (Mannino et al., 2006). It is 
one of the few diseases that continues to rise in numbers in many countries. COPD is an 
inflammatory disease characterized by airflow limitation that is not fully reversible (Celli & 
MacNee, 2004). The airflow limitation is caused by a combination of airway obstruction and 
parenchymal destruction (emphysema). The pulmonary changes in COPD lead to 
inhomogeneous regional ventilation. V/P SPECT is sufficiently sensitive as a method to 
identify the functional changes in COPD. In comparison with DTPA aerosols, Technegas 
penetrates the lung periphery better (Jögi et al., 2010), which is especially important in 
COPD (exemplified in Fig 3). Technegas ventilation imaging has been shown to visualise the 
early changes of COPD before they can be observed with high resolution CT (HRCT) (Yokoe 
et al., 2006). As COPD initially affects the airways, the ventilation defects are commonly 
more prominent than those of perfusion. Perfusion within the lungs also becomes abnormal 
as the lungs attempt to adapt the regional blood flow to ventilation to preserve an efficient 
gas exchange. Often this adaptation is incomplete and perfused but non-ventilated areas 
(low V/P ratio) occur, i.e. reverse mismatch (Gottschalk et al., 1993). With progressive 
disease, concurrent destruction of airways and blood vessels takes place and matched 
defects with absence of both ventilation and perfusion are seen. Vascular remodeling in 
COPD may lead to regions with elevated V/P ratios. Garg et al. (1983) found that the degree 
of abnormality on aerosol ventilation images significantly correlated to pulmonary function 
tests. In a recent paper, which evaluated the role of V/P SPECT in patients with COPD, it 
was shown that V/P SPECT correlated significantly both to traditional lung function tests as 
well as the extent of emphysema as measured with HRCT (Jögi et al., 2011). It was also 
shown that V/P SPECT could be used to characterize the severity of COPD. Pulmonary 
embolism and heart failure are common comorbidities with overlapping symptoms that 
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complicate the manifestation of COPD. The prevalence of PE in patients hospitalized with 
exacerbation has been reported to be as high as 25% but is generally under-diagnosed 
(Mispelaere et al., 2002; Tillie-Leblond et al., 2006). In patients with stable COPD, PE 
accounts for 10% of deaths (Schonhofer & Kohler, 1998). The prevalence of heart failure 
among patients with stable COPD has been reported to be about 20% and even higher in 
patients with exacerbation (Rizkallah et al., 2009; Rutten et al., 2006). The previous finding of 
the PIOPED study that V/P scintigraphy cannot be used to diagnose PE among patients 
with pathology of ventilation is an outdated belief (1990). Figure 7 shows extensive PE in a 
patient with COPD. This heavy smoker had a short history of progressive dyspnea. V/P 
SPECT showed uneven ventilation and perfusion with a pattern that is typical for COPD. 
Moreover, extensive perfusion defects were seen in areas with preserved ventilation. V/P 
quotient images could be used to quantify the extent of PE to approximately 70% of the lung 
parenchyma. 
 
 
Fig. 7. Patient with severe COPD and chronic PE. Frontal slices; ventilation is very uneven in 
the whole lung. In addition, multiple perfusion defects are seen in ventilated areas. 
Mismatches are highlighted in V/Pquotient images. 
6.2 Heart failure 
Left heart failure is a complex clinical syndrome that can result from any cardiac disorder 
that affects the ability of the left ventricle to function as a pump. When the left chamber is 
unable to meet the functional demands of the body, symptoms such as dyspnea and fatigue, 
as well as signs of pulmonary fluid retention appear. In patients with heart failure the risk of 
developing venous thromboembolic disease, including PE, is elevated (Anderson & Spencer, 
2003). As early as the 1960s, Friedman and Braunwald, West and others demonstrated that 
patients with mitral valve disease and left heart failure showed an inversion or 
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“cephalization” of the normal dependent distribution of blood flow (Friedman & 
Braunwald, 1966; West et al., 1964). The inverted distribution of blood flow to non-
dependent lung zones seen in heart failure has been correlated to elevated pulmonary 
venous pressure, interstitial oedema, alveolar space flooding and, when longstanding, 
perivascular fibrosis (Mohsenifar et al., 1989; Pistolesi et al., 1988). Ventilation is not affected 
to the same degree as perfusion and mismatch in the dependent lung is therefore common. 
This mismatch, however, is not of a segmental character. V/P SPECT can therefore identify 
patients with congestive heart failure. In a study of 247 patients examined with V/P SPECT 
for suspected PE, we found that 15% of the patients had signs of heart failure, sometimes in 
combination with PE (Jögi et al., 2008). Figure 8 shows a patient who suffered from 
increasing breathlessness. V/P SPECT was performed to exclude PE. V/P SPECT in supine 
position identified redistribution of ventilation and perfusion towards ventral regions (Fig 
8a). Perfusion is more affected than ventilation and mismatch is therefore observed. This is, 
however, non-segmental and the diagnosis was therefore reported as heart failure and not 
PE. After 12 days of anticongestive treatment, the patient had improved clinically and the 
follow-up V/P SPECT (Fig 8b) showed complete normalization of both ventilation and 
perfusion. 
 
 
Fig. 8. Patient with acute heart failure. A) In the supine patient, perfusion is redistributed to 
anterior parts of the lung. Ventilation is also affected but not to the same degree, which 
causes non-segmental perfusion defects. B). Follow up after 12 days of anticongestive 
treatment 
6.3 Pneumonia 
Pneumonia is an inflammatory condition of the lung parenchyma, especially affecting the 
alveoli. There are both infectious and non-infectious causes. The pneumonic regions of the 
lung become non-ventilated although the blood flow is often maintained to some extent. 
This can cause shunting and lead to hypoxemia. As the ventilation defect often exceeds the 
perfusion defect, reverse mismatch is a common finding (Carvalho & Lavender, 1989). In a 
study by Li et al. (1994) reverse mismatch represented pneumonia in 81% of the cases. In 
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severe cases both ventilation and perfusion are reduced or abolished and matched defects 
are then frequently found (Li et al., 1994). Another sign of pneumonia that often has been 
described is the “stripe sign” (Sostman & Gottschalk, 1982, 1992). The “stripe sign” refers to 
the observation of a stripe of a relatively well preserved perfusion adjacent to the pleural 
surface, by contrast with the more pronounced perfusion defects within the pneumonic 
lesion. This distinguishes pneumonia from the segmental perfusion defects found in PE. The 
enhanced performance of V/P SPECT compared to planar imaging has facilitated the 
detection of the stripe sign (Pace & Goris, 1998). 
Hampson as well as the ICOPER study illustrated that the risk of PE is increased in patients 
with pneumonia or other coexisting diseases (Elliott et al., 2000; Hampson, 1995). In the 
ICOPER study, 17% of 2000 patients with confirmed PE had infiltrates on chest X-ray. 
Pneumonia has also been shown to be a common finding in patients with autopsy proven 
PE (Mandelli et al., 1997). 
7. Radiation exposure 
The doses of 30 MBq and 120 MBq for ventilation and perfusion, respectively, allows 
excellent V/P SPECT  quality at an effective radiation dose of 1.8 mSv (ICRP, 1998). The 
absorbed dose to the breasts with V/P SPECT is 0.8 mGy (ICRP, 1998). Estimation of 
exposure is relatively easy when short-lived radio-isotopes are used in nuclear medicine. In 
contrast, for X-ray technologies this is much more difficult because of a number of factors, 
such as differences in equipment and the size of the exposed fields. According to ICRP, the 
average effective dose for 4–16-detector MDCT is 5.4 mSv (Valentin, 2007). Notably, this 
information was based on computed rather than measured dose data. Hurwitz et al. reported 
for a current adult PE protocol with 64-detector MDCT a measured effective dose of 19.9±1.38 
mSv (Hurwitz et al., 2007). These authors point out that the actual measured dose is about 50% 
higher than the computed dose. The absorbed dose to the breasts was 35–42 mGy. Absorbed 
radiation dose to the breast for a single-slice CT study was 20–50 mGy and 30– 50% greater 
with a four-slice CT. In a very recent study, Hurwitz et al. (Hurwitz et al., 2009) studied 
radiation dose-saving protocols. Phantoms of women were exposed to MDCT protocols with 
automatic current modulation, lower tube voltage and bismuth shields over the chest. In the 
case of a medium sized female patient when automatic current modulation was applied at 140 
kVp, breast doses were estimated at 62 mGy and this reduced to 33 mGy when bismuth 
shields were added. At 120 kVp the doses were 44 mGy without shields and 20 mGy with 
shields. Some limitations of the study were discussed. No phantom with significant 
subcutaneous fat was studied. The authors were not able to directly assess the effect of 
increased noise for the diagnosis of PE. Dose-saving protocols are promising. 
8. Conclusions 
The superiority of V/P SPECT over other imaging techniques in the diagnosis of PE has been 
well demonstrated. The examination is without contraindication and can be performed in 99% 
of patients with suspected PE. V/P SPECT makes it possible to quantify the extent of perfusion 
loss, so that PE treatment can be better adapted to the needs of individual patients. By using 
V/P SPECT, it is also possible to diagnose other cardiopulmonary conditions.  
Because of the very low radiation exposure, it is an ideal method for evaluating treatment 
and follow up. Low radiation doses are particularly important for women in the 
reproductive period and during pregnancy. 
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The above mentioned advantages of V/P SPECT for studying PE lead to the conclusion that 
it is the only suitable technique both for follow-up in patients with PE as well as for 
validation of treatment therapies. Moreover, it is an essential tool for research. 
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management are highlighted. Non-thrombotic pulmonary emboli are also covered and an attempt is made to
constitute an awareness of this picture that can change the treatment and prognosis of the disease to a
considerable extent. In addition to the pathophysiological definition of pulmonary embolus, the priority goal of
quick and definitive diagnosis is emphasized, and diagnostic strategies are discussed in the book. A numerical
analysis of the vena cava filters, which is a current approach to prevent pulmonary emboli recurrences, is
presented in the last chapter.
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